Imricor Medical Systems (IMR.AX) Earnings Analysis
Imricor Medical Systems (IMR.AX) next reports earnings on 2026-09-01. Trailing P/E -21.64.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does IMR.AX next report earnings?
| Next earnings date | 2026-09-01 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.00B |
IMR.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-10-16 | -0.03597 AUD | n/a | n/a | n/a |
IMR.AX valuation and analyst view
| Trailing P/E | -21.64 |
|---|---|
| Trailing EPS | -0.05911 AUD |
| Price / book | 36.62 |
| Dividend yield | 0.00% |
| Market cap | 0.42B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Imricor Medical Systems (IMR.AX)'s next earnings date?
Imricor Medical Systems is next scheduled to report on 2026-09-01 and revenue estimate of 0.00B.
Did IMR.AX beat earnings last quarter?
Consensus estimate data was not available for IMR.AX's 2024-10-16 report.
What is IMR.AX's current P/E ratio and EPS?
IMR.AX trades at a trailing P/E of -21.64 on trailing EPS of -0.05911117830946233 AUD.
What do analysts rate IMR.AX?
IMR.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.